Exact Mass: 317.1086

Exact Mass Matches: 317.1086

Found 83 metabolites which its exact mass value is equals to given mass value 317.1086, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Tsitsikammamine B

Tsitsikammamine B

C19H15N3O2 (317.1164)


   

5,4-Dimethyl-6-hydroxyluteolinidin

6,7,3-Trihydroxy-5,4-dimethoxy-flavylium

C17H17O6 (317.1025)


   
   

Methyl 2-cyano-3-(2-morpholino-5-nitrophenyl)acrylate

Methyl 2-cyano-3-(2-morpholino-5-nitrophenyl)acrylate

C15H15N3O5 (317.1012)


   

8,13,13b,14-Tetrahydro-14-formylindolo[2,3:3,4]pyrido[2,1-b]quinazoline-5(7H)-one

8,13,13b,14-Tetrahydro-14-formylindolo[2,3:3,4]pyrido[2,1-b]quinazoline-5(7H)-one

C19H15N3O2 (317.1164)


   
   
   

2-Methoxyruteacaprine

2-Methoxyruteacaprine

C19H15N3O2 (317.1164)


   
   
   

N,1,2,5-Tetra-Ac-beta-D-Furnose-3-Amino-3-deoxyribose

N,1,2,5-Tetra-Ac-beta-D-Furnose-3-Amino-3-deoxyribose

C13H19NO8 (317.1111)


   

Pauridianthinol

Pauridianthinol

C19H15N3O2 (317.1164)


   
   

mycosporine-glu

mycosporine-glu

C13H19NO8 (317.1111)


   

14-Formyldihydrorutaecarpine

14-Formyldihydrorutaecarpine

C19H15N3O2 (317.1164)


   

Tsitsikammamine A N-oxime / B

Tsitsikammamine A N-oxime / B

C19H15N3O2 (317.1164)


   

Oxyphenisatin

Oxyphenisatine

C20H15NO3 (317.1052)


CONFIDENCE standard compound; INTERNAL_ID 625; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3927; ORIGINAL_PRECURSOR_SCAN_NO 3925 A - Alimentary tract and metabolism > A06 - Drugs for constipation > A06A - Drugs for constipation > A06AB - Contact laxatives C78276 - Agent Affecting Digestive System or Metabolism > C29697 - Laxative D005765 - Gastrointestinal Agents > D002400 - Cathartics CONFIDENCE standard compound; INTERNAL_ID 625; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3937; ORIGINAL_PRECURSOR_SCAN_NO 3935 CONFIDENCE standard compound; INTERNAL_ID 625; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3903; ORIGINAL_PRECURSOR_SCAN_NO 3901 CONFIDENCE standard compound; INTERNAL_ID 625; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3930; ORIGINAL_PRECURSOR_SCAN_NO 3928 CONFIDENCE standard compound; INTERNAL_ID 625; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3916; ORIGINAL_PRECURSOR_SCAN_NO 3914 CONFIDENCE standard compound; INTERNAL_ID 625; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3917; ORIGINAL_PRECURSOR_SCAN_NO 3916 CONFIDENCE standard compound; INTERNAL_ID 625; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7947; ORIGINAL_PRECURSOR_SCAN_NO 7945 CONFIDENCE standard compound; INTERNAL_ID 625; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7982; ORIGINAL_PRECURSOR_SCAN_NO 7981 CONFIDENCE standard compound; INTERNAL_ID 625; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7987; ORIGINAL_PRECURSOR_SCAN_NO 7982 CONFIDENCE standard compound; INTERNAL_ID 625; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8022; ORIGINAL_PRECURSOR_SCAN_NO 8020 CONFIDENCE standard compound; INTERNAL_ID 625; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8036; ORIGINAL_PRECURSOR_SCAN_NO 8034 CONFIDENCE standard compound; INTERNAL_ID 625; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8042; ORIGINAL_PRECURSOR_SCAN_NO 8039

   

3,N4-Benzoquinone-deoxycytodine

3,N4-Benzoquinone-deoxycytodine

C15H15N3O5 (317.1012)


   

5,4-Dimethyl-6-hydroxyluteolinidin

6,7,3-Trihydroxy-5,4-dimethoxy-flavylium

C17H17O6+ (317.1025)


   

2-quinolin-2-yl-1-[4-(trifluoromethyl)phenyl]ethanol

2-quinolin-2-yl-1-[4-(trifluoromethyl)phenyl]ethanol

C18H14F3NO (317.1027)


   

2,3-dihydroxybutanedioic acid,3-[1-hydroxy-2-(methylamino)ethyl]phenol

2,3-dihydroxybutanedioic acid,3-[1-hydroxy-2-(methylamino)ethyl]phenol

C13H19NO8 (317.1111)


   

Synephrine tartrate

Synephrine tartrate

C13H19NO8 (317.1111)


   

Metaraminol bitartrate

Metaraminol bitartrate

C13H19NO8 (317.1111)


D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents

   

Imipenem

Imipenem hydrate

C12H19N3O5S (317.1045)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D013845 - Thienamycins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

   

1-(4-(4-Nitro-3-(trifluoromethyl)phenyl)piperazin-1-yl)ethanone

1-(4-(4-Nitro-3-(trifluoromethyl)phenyl)piperazin-1-yl)ethanone

C13H14F3N3O3 (317.0987)


   

2-quinolin-4-yl-1-[4-(trifluoromethyl)phenyl]ethanol

2-quinolin-4-yl-1-[4-(trifluoromethyl)phenyl]ethanol

C18H14F3NO (317.1027)


   

(R)-2-(((BENZYLOXY)CARBONYL)AMINO)-3-(2-FLUOROPHENYL)PROPANOIC ACID

(R)-2-(((BENZYLOXY)CARBONYL)AMINO)-3-(2-FLUOROPHENYL)PROPANOIC ACID

C17H16FNO4 (317.1063)


   

(S)-2-(((BENZYLOXY)CARBONYL)AMINO)-3-(2-FLUOROPHENYL)PROPANOIC ACID

(S)-2-(((BENZYLOXY)CARBONYL)AMINO)-3-(2-FLUOROPHENYL)PROPANOIC ACID

C17H16FNO4 (317.1063)


   

(S)-2-(((BENZYLOXY)CARBONYL)AMINO)-3-(3-FLUOROPHENYL)PROPANOIC ACID

(S)-2-(((BENZYLOXY)CARBONYL)AMINO)-3-(3-FLUOROPHENYL)PROPANOIC ACID

C17H16FNO4 (317.1063)


   

7-METHOXY-2,3-DIHYDRO-BENZOFURAN-3-YLAMINEHYDROCHLORIDE

7-METHOXY-2,3-DIHYDRO-BENZOFURAN-3-YLAMINEHYDROCHLORIDE

C18H20ClNO2 (317.1182)


   

N-Dipropyldopamine hydrobromide

N-Dipropyldopamine hydrobromide

C14H24BrNO2 (317.099)


   

Z-4-Fluoro-Phe-OH

Z-4-Fluoro-Phe-OH

C17H16FNO4 (317.1063)


   

Phenylephrine tartrate

(-)-Phenylephrine hydrogentartrate

C13H19NO8 (317.1111)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist

   

1-benzhydrylazetidin-3-yl Methanesulfonate

1-benzhydrylazetidin-3-yl Methanesulfonate

C17H19NO3S (317.1086)


   

N-Methyl-2,2-iminodi(8-quinolinol)

N-Methyl-2,2-iminodi(8-quinolinol)

C19H15N3O2 (317.1164)


   

RS 127445

RS 127445

C17H17ClFN3 (317.1095)


RS-127445 hydrochloride is a selective, high affinity, orally bioavailable 5-HT2B receptor antagonist with a pKi of 9.5. RS-127445 hydrochloride shows 1000 fold selectivity for this receptor as compared to numerous other receptor and ion channel binding sites[1].

   

ETHYL 2-((4-(BENZYLOXY)-3-FLUOROPHENYL)AMINO)-2-OXOACETATE

ETHYL 2-((4-(BENZYLOXY)-3-FLUOROPHENYL)AMINO)-2-OXOACETATE

C17H16FNO4 (317.1063)


   
   

4-[(2-Biphenylylcarbonyl)amino]benzoic acid

4-[(2-Biphenylylcarbonyl)amino]benzoic acid

C20H15NO3 (317.1052)


   

tri-n-butylcyanotin

tri-n-butylcyanotin

C13H27NSn (317.1165)


   
   
   

N-Methyl-N-((3R,4R)-4-Methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyriMidin-4-aMine dihydrochloride

N-Methyl-N-((3R,4R)-4-Methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyriMidin-4-aMine dihydrochloride

C13H21Cl2N5 (317.1174)


   

(S)-7-(7-amino-5-azaspiro[2.4]heptan-5-yl)-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid

(S)-7-(7-amino-5-azaspiro[2.4]heptan-5-yl)-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid

C16H16FN3O3 (317.1176)


   

(R)-2-(2,5-difluorophenyl)pyrrolidine (R)-2-hydroxysuccinate

(R)-2-(2,5-difluorophenyl)pyrrolidine (R)-2-hydroxysuccinate

C14H17F2NO5 (317.1075)


   

4,4,5,5-Tetramethyl-2-(2-nitro-5-(trifluoromethyl)phenyl)-1,3,2-dioxaborolane

4,4,5,5-Tetramethyl-2-(2-nitro-5-(trifluoromethyl)phenyl)-1,3,2-dioxaborolane

C13H15BF3NO4 (317.1046)


   

2,2,2-trifluoro-N-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-yl]acetamide

2,2,2-trifluoro-N-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-yl]acetamide

C12H15BF3N3O3 (317.1159)


   

2-QUINOLIN-2-YL-1-(3-TRIFLUROMETHYLPHENYL)ETHANOL

2-QUINOLIN-2-YL-1-(3-TRIFLUROMETHYLPHENYL)ETHANOL

C18H14F3NO (317.1027)


   

3-Methyl-6-chloro-2,3,4,5-tetrahydro-7,8-dihydroxy-1-(3-methylphenyl)-1H-3-benzazepine

3-Methyl-6-chloro-2,3,4,5-tetrahydro-7,8-dihydroxy-1-(3-methylphenyl)-1H-3-benzazepine

C18H20ClNO2 (317.1182)


SKF83959 is a potent and selective dopamine D1-like receptor partial agonist. SKF83959 Ki values for rat D1, D5, D2 and D3 receptors are 1.18, 7.56, 920 and 399 nM, respectively. SKF83959 is a potent allosteric modulator of sigma (σ)-1 receptor. SKF83959 belongs to benzazepine family and has improvements on cognitive dysfunction. SKF83959 can be used for the research of Alzheimer's disease and depression[1][2][3][4].

   

N-(2,2,4-trimethyl-2,3-dihydro-1-benzofuran-7-yl)benzenesulfonamide

N-(2,2,4-trimethyl-2,3-dihydro-1-benzofuran-7-yl)benzenesulfonamide

C17H19NO3S (317.1086)


   

2-(2-Deoxy-beta-D-erythro-pentofuranosyl)-7-hydroxypyrimido(1,6-a)benzimidazol-1(2H)-one

2-(2-Deoxy-beta-D-erythro-pentofuranosyl)-7-hydroxypyrimido(1,6-a)benzimidazol-1(2H)-one

C15H15N3O5 (317.1012)


   

3-Carbamoyl-5-(4-phenylphenyl)benzoic acid

3-Carbamoyl-5-(4-phenylphenyl)benzoic acid

C20H15NO3 (317.1052)


   

1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-[2-(methylamino)ethyl]-2-sulfanylidenepyrimidin-4-one

1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-[2-(methylamino)ethyl]-2-sulfanylidenepyrimidin-4-one

C12H19N3O5S (317.1045)


   

1-[4-[2-Nitro-4-(trifluoromethyl)phenyl]piperazin-1-yl]ethanone

1-[4-[2-Nitro-4-(trifluoromethyl)phenyl]piperazin-1-yl]ethanone

C13H14F3N3O3 (317.0987)


   

2-(3-Formyl-2,5-dimethyl-1-pyrrolyl)-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylic acid methyl ester

2-(3-Formyl-2,5-dimethyl-1-pyrrolyl)-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylic acid methyl ester

C17H19NO3S (317.1086)


   

2-[[1-(4-Chlorophenyl)-4-pyrazolo[3,4-d]pyrimidinyl]amino]-1-butanol

2-[[1-(4-Chlorophenyl)-4-pyrazolo[3,4-d]pyrimidinyl]amino]-1-butanol

C15H16ClN5O (317.1043)


   

1-(4-chlorophenyl)-N-(1-methoxypropan-2-yl)-4-pyrazolo[3,4-d]pyrimidinamine

1-(4-chlorophenyl)-N-(1-methoxypropan-2-yl)-4-pyrazolo[3,4-d]pyrimidinamine

C15H16ClN5O (317.1043)


   

2-[[2-furanyl(oxo)methyl]hydrazo]-N-(2-methoxy-5-methylphenyl)-2-oxoacetamide

2-[[2-furanyl(oxo)methyl]hydrazo]-N-(2-methoxy-5-methylphenyl)-2-oxoacetamide

C15H15N3O5 (317.1012)


   

3-[(1R,2S)-2-amino-1-hydroxypropyl]phenol dihydrogen (2R,3R)-2,3-dihydroxybutanedioate

3-[(1R,2S)-2-amino-1-hydroxypropyl]phenol dihydrogen (2R,3R)-2,3-dihydroxybutanedioate

C13H19NO8 (317.1111)


   

N-(furan-2-ylmethyl)-N-[(Z)-(2-hydroxy-3-methoxyphenyl)methylideneamino]oxamide

N-(furan-2-ylmethyl)-N-[(Z)-(2-hydroxy-3-methoxyphenyl)methylideneamino]oxamide

C15H15N3O5 (317.1012)


   

(8E)-8-[(2-fluoroanilino)hydrazinylidene]-1,3-dimethylpurine-2,6-dione

(8E)-8-[(2-fluoroanilino)hydrazinylidene]-1,3-dimethylpurine-2,6-dione

C13H12FN7O2 (317.1036)


   

N-[2-[(2Z)-2-[(2-hydroxy-3-methoxyphenyl)methylidene]hydrazinyl]-2-oxoethyl]furan-2-carboxamide

N-[2-[(2Z)-2-[(2-hydroxy-3-methoxyphenyl)methylidene]hydrazinyl]-2-oxoethyl]furan-2-carboxamide

C15H15N3O5 (317.1012)


   

(1S)-14-oxo-3,13,21-triazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-2(10),4,6,8,15,17,19-heptaene-21-carbaldehyde

(1S)-14-oxo-3,13,21-triazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-2(10),4,6,8,15,17,19-heptaene-21-carbaldehyde

C19H15N3O2 (317.1164)


   

Oxyphenisatine

Oxyphenisatine

C20H15NO3 (317.1052)


A - Alimentary tract and metabolism > A06 - Drugs for constipation > A06A - Drugs for constipation > A06AB - Contact laxatives C78276 - Agent Affecting Digestive System or Metabolism > C29697 - Laxative D005765 - Gastrointestinal Agents > D002400 - Cathartics

   

6,7,3-Trihydroxy-5,4-dimethoxy-flavylium

6,7,3-Trihydroxy-5,4-dimethoxy-flavylium

C17H17O6+ (317.1025)


   

5,4'-Dimethyl-6-hydroxyluteolinidin

5,4'-Dimethyl-6-hydroxyluteolinidin

C17H17O6 (317.1025)


   

9-hydroxy-7-methoxy-13-methyl-10-azapentacyclo[9.7.1.0²,¹⁰.0³,⁸.0¹⁵,¹⁹]nonadeca-1,3(8),4,6,11,13,15(19),16-octaen-18-one

9-hydroxy-7-methoxy-13-methyl-10-azapentacyclo[9.7.1.0²,¹⁰.0³,⁸.0¹⁵,¹⁹]nonadeca-1,3(8),4,6,11,13,15(19),16-octaen-18-one

C20H15NO3 (317.1052)


   

8-(1h-indol-3-yl)-2-methoxy-6-methylnaphthalene-1,4-dione

8-(1h-indol-3-yl)-2-methoxy-6-methylnaphthalene-1,4-dione

C20H15NO3 (317.1052)


   

(4ar,7s)-6,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-5-methoxy-4a,7-dihydro-1λ⁴-chromen-1-ylium

(4ar,7s)-6,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-5-methoxy-4a,7-dihydro-1λ⁴-chromen-1-ylium

[C17H17O6]+ (317.1025)


   

14-fomyldihydroxyrutaecarpine

NA

C19H15N3O2 (317.1164)


{"Ingredient_id": "HBIN001457","Ingredient_name": "14-fomyldihydroxyrutaecarpine","Alias": "NA","Ingredient_formula": "C19H15N3O2","Ingredient_Smile": "C1CN2C(C3=C1C4=CC=CC=C4N3)N(C5=CC=CC=C5C2=O)C=O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "30970","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

acalyphine

NA

C13H19NO8 (317.1111)


{"Ingredient_id": "HBIN014320","Ingredient_name": "acalyphine","Alias": "NA","Ingredient_formula": "C13H19NO8","Ingredient_Smile": "CN1C=C(C(=CC1=O)OC)OC2C(C(C(C(O2)CO)O)O)O","Ingredient_weight": "0","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "23592","TCMSP_id": "NA","TCM_ID_id": "7249","PubChem_id": "NA","DrugBank_id": "NA"}

   

18-hydroxy-5,9,9-trimethyl-4,8,17-triazapentacyclo[10.6.1.0²,¹⁰.0³,⁸.0¹⁶,¹⁹]nonadeca-1,3,5,10,12,14,16(19),17-octaen-7-one

18-hydroxy-5,9,9-trimethyl-4,8,17-triazapentacyclo[10.6.1.0²,¹⁰.0³,⁸.0¹⁶,¹⁹]nonadeca-1,3,5,10,12,14,16(19),17-octaen-7-one

C19H15N3O2 (317.1164)


   

3-(4-hydroxyphenyl)-9-methyl-5,9,14-triazatetracyclo[6.6.1.0²,⁶.0¹¹,¹⁵]pentadeca-1(14),2(6),3,8(15),10-pentaen-7-one

3-(4-hydroxyphenyl)-9-methyl-5,9,14-triazatetracyclo[6.6.1.0²,⁶.0¹¹,¹⁵]pentadeca-1(14),2(6),3,8(15),10-pentaen-7-one

C19H15N3O2 (317.1164)


   

6-methoxy-3,13,21-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-1(21),2(10),4,6,8,15,17,19-octaen-14-one

6-methoxy-3,13,21-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-1(21),2(10),4,6,8,15,17,19-octaen-14-one

C19H15N3O2 (317.1164)


   

18-methoxy-3,13,21-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-1(21),2(10),4,6,8,15,17,19-octaen-14-one

18-methoxy-3,13,21-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-1(21),2(10),4,6,8,15,17,19-octaen-14-one

C19H15N3O2 (317.1164)


   

2-{[5-hydroxy-5-(hydroxymethyl)-2-methoxy-3-oxocyclohex-1-en-1-yl]amino}pentanedioic acid

2-{[5-hydroxy-5-(hydroxymethyl)-2-methoxy-3-oxocyclohex-1-en-1-yl]amino}pentanedioic acid

C13H19NO8 (317.1111)


   

7-methoxy-3,13,21-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-1(21),2(10),4,6,8,15,17,19-octaen-14-one

7-methoxy-3,13,21-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-1(21),2(10),4,6,8,15,17,19-octaen-14-one

C19H15N3O2 (317.1164)


   

(1s)-14-oxo-3,13,21-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8,15,17,19-heptaene-21-carbaldehyde

(1s)-14-oxo-3,13,21-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8,15,17,19-heptaene-21-carbaldehyde

C19H15N3O2 (317.1164)


   

n-(2-{12-oxo-8,14-diazatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,10,13,15-octaen-10-yl}ethyl)ethanimidic acid

n-(2-{12-oxo-8,14-diazatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,10,13,15-octaen-10-yl}ethyl)ethanimidic acid

C19H15N3O2 (317.1164)


   

19-methoxy-3,13,21-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-1(21),2(10),4,6,8,15,17,19-octaen-14-one

19-methoxy-3,13,21-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-1(21),2(10),4,6,8,15,17,19-octaen-14-one

C19H15N3O2 (317.1164)


   

(2s)-2-{[(5r)-5-hydroxy-5-(hydroxymethyl)-2-methoxy-3-oxocyclohex-1-en-1-yl]amino}pentanedioic acid

(2s)-2-{[(5r)-5-hydroxy-5-(hydroxymethyl)-2-methoxy-3-oxocyclohex-1-en-1-yl]amino}pentanedioic acid

C13H19NO8 (317.1111)


   

14-oxo-3,13,21-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8,15,17,19-heptaene-21-carbaldehyde

14-oxo-3,13,21-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8,15,17,19-heptaene-21-carbaldehyde

C19H15N3O2 (317.1164)


   

(2s)-4-(c-hydroxycarbonimidoyl)-2-[(3-hydroxyquinolin-2-yl)formamido]butanoic acid

(2s)-4-(c-hydroxycarbonimidoyl)-2-[(3-hydroxyquinolin-2-yl)formamido]butanoic acid

C15H15N3O5 (317.1012)